Revance Logo
COMPANYPRODUCTS AND PIPELINEINVESTORSCAREERSIN THE NEWSCONTACT US
ABOUTLEADERSHIPBOARDPARTNERSHIPS
SUSTAINABILITYMEDICAL EDUCATIONAL GRANTSINVESTIGATOR SPONSORED TRIALS
Company
INVESTOR RELATIONSPRESS RELEASESEVENTS + PRESENTATIONSFINANCIALS & FILINGSCORPORATE GOVERNANCE
STOCK INFORMATIONANALYST COVERAGEINVESTOR FAQSCONTACT US
Investors
OPPORTUNITIESCULTUREBENEFITS
Careers
COMPANYPRODUCTS AND PIPELINEINVESTORSCAREERSIN THE NEWSCONTACT US
Facebook logoInstagram logoTwitter logoLinkedIn logo
1222 Demonbreun St
20th Floor
Nashville, TN 37203
+1 (510) 742-3400
LoginContact Revance
Back
May 8, 2019
Revance Reports First Quarter 2019 Financial Results and Provides Corporate Update
April 24, 2019
Revance to Release First Quarter 2019 Financial Results on Wednesday, May 8, 2019
April 9, 2019
Revance Appoints Former Allergan Marketing Veteran Taryn Conway as Vice President of Marketing
April 8, 2019
SAKURA 3 Trial Results Presented on Podium at World’s Largest Medical Aesthetic Conference
April 2, 2019
Revance to Participate in the Needham Healthcare Conference
March 5, 2019
Revance to Participate in Upcoming Investor Conferences
February 26, 2019
Revance Releases Fourth Quarter and Full Year 2018 Results
February 12, 2019
Revance to Release Fourth Quarter and Full Year 2018 Financial Results on Tuesday, February 26, 2019
January 22, 2019
Revance Announces Closing of Public Offering of Common Stock
January 17, 2019
Revance Announces Pricing of Public Offering of Common Stock
Displaying 141 - 150 of 305